SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-023815
Filing Date
2021-02-01
Accepted
2021-02-01 08:11:53
Documents
14
Period of Report
2021-01-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d118525d8k.htm   iXBRL 8-K 24173
2 EX-99.1 d118525dex991.htm EX-99.1 8662
6 GRAPHIC g118525dsp002.jpg GRAPHIC 4429
  Complete submission text file 0001193125-21-023815.txt   161521

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zsan-20210129.xsd EX-101.SCH 3081
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20210129_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20210129_pre.xml EX-101.PRE 10960
7 EXTRACTED XBRL INSTANCE DOCUMENT d118525d8k_htm.xml XML 3270
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 21574426
SIC: 2834 Pharmaceutical Preparations